This model labels KRT19+AXIN2+ cells with tdTomato (Tom) upon tamoxifen administration, enabling the tracking of KRT19+AXIN2+ (Tom+) cell dynamics during ICC tumorigenesis (Figure 2F). The gene discussed is AXIN2; the disease is intrahepatic cholangiocarcinoma.